NASDAQ:AVRO
AVROBIO, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.avrobio.comipo date
Jun 21, 2018
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's pr...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus